NCT04766385View on ClinicalTrials.gov

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Hyperphosphatemia
Interventions
DRUG

KHK7791

oral administration

Trial Locations (1)

Unknown

Inoue Hospital, Suita

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04766385 - Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter